Uncoupling of S phase and mitosis induced by anticancer agents in cells lacking p21
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Precise coordination of the S and M phases of the eukaryotic cell cycle is critical not only for normal cell division, but also for effective growth arrest under conditions of stress. When damaged, a cell must communicate signals to both the mitotic and DNA synthesis machineries so that a mitotic block is not followed by an extra S phase, or vice versa. The biochemical mechanisms regulating this coordination, termed checkpoints, have been identified in lower eukaryotes, but are largely unknown in mammalian cells. Here we show that p21 WAF1/CIP1, the prototype inhibitor of cyclin-dependent kinases (CDKs), is required for this coordination in human cells. In the absence of p21, DNA-damaged cells arrest in a G2-like state, but then undergo additional S phases without intervening normal mitoses. They thereby acquire grossly deformed, polyploid nuclei and subsequently die through apoptosis. Perhaps not by coincidence, the DNA-damaging agents that can cause S/M uncoupling are used in the clinic to kill cancer cells preferentially.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, after transiently arresting in G2, HCT-116 cells in which p21 was knocked out eventually underwent aberrant mitoses, leading to polyploidy or cell death.53,55”
From Senescence from G2 arrest, revisited (2015) · cites this paper as [53]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
Hartwell, L. H., & Kastan, M. B. (1994) · Science · doi:10.1126/science.7997877 · Cited by 2,535
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Di Leonardo, A., Linke, S. P., Clarkin, K., & Wahl, G. M. (1994) · Genes & Development · doi:10.1101/gad.8.21.2540 · Cited by 1,215
p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.
Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., & Jacks, T. (1995) · Genes & Development · doi:10.1101/gad.9.8.935 · Cited by 1,119
Self-citationGorczyca, W., GONG, J., & Darżynkiewicz, Z. (1993) · PubMed · Cited by 982
Creative blocks: cell-cycle checkpoints and feedback controls
Murray, A. W. (1992) · Nature · doi:10.1038/359599a0 · Cited by 663
A p53-Dependent Mouse Spindle Checkpoint
Cross, S. M., Sanchez, C. A., Morgan, C. A., Schimke, M. K., Ramel, S., Idzerda, R. L., Raskind, W. H., & Reid, B. J. (1995) · Science · doi:10.1126/science.7871434 · Cited by 660
Ordering S phase and M phase in the cell cycle
Nurse, P. (1994) · Cell · doi:10.1016/0092-8674(94)90539-8 · Cited by 589
Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues.
El‐Deiry, W. S., Tokino, T., Waldman, T. A., Oliner, J., Velculescu, V. E., Burrell, M., HILL, D. E., Healy, E., Rees, J. L., & Hamilton, S. R. (1995) · PubMed · Cited by 582
Self-citation
Research works printed but not linked: 8
- Waldman, T., Kinzler, K. W. & Vogelstein, B. Cancer Res. 55, 5187–5190 (1995).
- Gorczyca, W., Gong, J. & Darzynkiewicz, Z. Cancer Res. 53, 1945–1951 (1993).
- Gao, X. et al. Oncogene 11, 1395–1398 (1995).
- El-Deiry, W. A. et al. Cancer Res. 55, 2910–2919 (1995).
- Kung, A. L., Zetterberg, A., Sherwood, S. W. & Schimke, R. T. Cancer Res. 50, 7307–7317 (1990).
- Carder, P. et al. Oncogene 8, 1397–1401 (1993).
- Harvey, M. et al. Oncogene 8, 2457–2467 (1993).
- Morrow, C. S. & Cowan, K. H. in Cancer Medicine (eds Holland, J. F. et al.), 618–631 (Lea & Febiger, Philadelphia, 1993).
Cited by
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Genetic instabilities in human cancers
Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/25292 · Cited by 4,168
Self-citationRequirement for p53 and p21 to Sustain G 2 Arrest After DNA Damage
Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, J. P., Sedivy, J. M., Kinzler, K. W., & Vogelstein, B. (1998) · Science · doi:10.1126/science.282.5393.1497 · Cited by 2,803
Self-citationAP-1 in cell proliferation and survival
Shaulian, E., & Karin, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204383 · Cited by 1,736
Mutations of mitotic checkpoint genes in human cancers
Cahill, D. P., Lengauer, C., Yu, J., Riggins, G. J., Willson, J. K. V., Markowitz, S. D., Kinzler, K. W., & Vogelstein, B. (1998) · Nature · doi:10.1038/32688 · Cited by 1,486
Self-citationPUMA Induces the Rapid Apoptosis of Colorectal Cancer Cells
Yu, J., Zhang, L., Hwang, P. M., Kinzler, K. W., & Vogelstein, B. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00213-1 · Cited by 1,280
Self-citationIs a p53-Regulated Inhibitor of G2/M Progression
Hermeking, H., Lengauer, C., Polyak, K., He, T.-C., Zhang, L., Thiagalingam, S., Kinzler, K. W., & Vogelstein, B. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80002-7 · Cited by 1,251
Self-citationDisruption of p53 in human cancer cells alters the responses to therapeutic agents.
Bunz, F., Hwang, P. M., Torrance, C., Waldman, T., Zhang, Y., Dillehay, L., Williams, J., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6863 · Cited by 1,044
Self-citation(1999) · PubMed · Cited by 1,030
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
14-3-3σ is required to prevent mitotic catastrophe after DNA damage
Chan, T. A., Hermeking, H., Lengauer, C., Kinzler, K. W., & Vogelstein, B. (1999) · Nature · doi:10.1038/44188 · Cited by 895
Self-citationRole of BAX in the Apoptotic Response to Anticancer Agents
Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., & Vogelstein, B. (2000) · Science · doi:10.1126/science.290.5493.989 · Cited by 863
Self-citationStructure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA
Gulbis, J. M., Kelman, Z., Hurwitz, J., O'Donnell, M., & Kuriyan, J. (1996) · Cell · doi:10.1016/s0092-8674(00)81347-1 · Cited by 804
Bypass of Senescence After Disruption of p21 CIP1/WAF1 Gene in Normal Diploid Human Fibroblasts
Brown, J. P., Wei, W., & Sedivy, J. M. (1997) · Science · doi:10.1126/science.277.5327.831 · Cited by 804
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells
Michel, L. S., Liberal, V., Chatterjee, A., Kirchwegger, R., Pasche, B., Gerald, W., Dobles, M., Sorger, P. K., Murty, V. V. V. S., & Benezra, R. (2001) · Nature · doi:10.1038/35053094 · Cited by 723
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
Niculescu, A. B., Chen, X., Smeets, M., Hengst, L., Prives, C., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.629 · Cited by 724
Death through a tragedy: mitotic catastrophe
Vakifahmetoglu, H., Olsson, M., & Zhivotovsky, B. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.47 · Cited by 700
Apoptosis, p53, and tumor cell sensitivity to anticancer agents.
Brown, J. M., & Wouters, B. G. (1999) · PubMed · Cited by 696
GADD45 induction of a G 2 /M cell cycle checkpoint
Wang, X. W., Zhan, Q., Coursen, J. D., Khan, M. A., Kontny, H. U., Yu, L., Hollander, M. C., O’Connor, P. M., Fornace, A. J., & Harris, C. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3706 · Cited by 634
erbB-2, p53, and Efficacy of Adjuvant Therapy in Lymph Node-Positive Breast Cancer
Thor, A. D., Berry, D. A., Budman, D. R., Muss, H. B., Kute, T., Henderson, I. C., Barcos, M., Cirrincione, C., Edgerton, S., Allred, C., et al. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.18.1346 · Cited by 612
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
Li, F., Ackermann, E. J., Bennett, C. F., Rothermel, A. L., Plescia, J., Tognin, S., Villa, A., Marchisio, P. C., & Altieri, D. C. (1999) · Nature Cell Biology · doi:10.1038/70242 · Cited by 600
KLF4, p21 and context-dependent opposing forces in cancer
Rowland, B. D., & Peeper, D. S. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1780 · Cited by 551
(1999) · PubMed · Cited by 546
HuR Regulates p21 mRNA Stabilization by UV Light
Wang, W., Furneaux, H., Cheng, H., Caldwell, M. C., Hutter, D., Liu, Y., Holbrook, N., & Gorospe, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.760-769.2000 · Cited by 539
p21 WAF1 is required for butyrate-mediated growth inhibition of human colon cancer cells
Archer, S. Y., Meng, S., Shei, A., & Hodin, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.6791 · Cited by 535
Funk, J. O., Waga, S., Harry, J. B., Espling, E., Stillman, B., & Galloway, D. A. (1997) · Genes & Development · doi:10.1101/gad.11.16.2090 · Cited by 419
p21WAF1/Cip1: more than a break to the cell cycle?
Dotto, G. P. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(00)00019-6 · Cited by 474
Anticancer drug targets: cell cycle and checkpoint control
Shapiro, G. I., & Harper, J. W. (1999) · Journal of Clinical Investigation · doi:10.1172/jci9054 · Cited by 464
Genetic determinants of p53-induced apoptosis and growth arrest.
Polyak, K., Waldman, T., He, T. C., Kinzler, K. W., & Vogelstein, B. (1996) · Genes & Development · doi:10.1101/gad.10.15.1945 · Cited by 459
Self-citationIdentification and classification of p53-regulated genes
Yu, J., Zhang, L., Hwang, P. M., Rago, C., Kinzler, K. W., & Vogelstein, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14517 · Cited by 452
Self-citationRoninson, I. B. (2002) · Cancer Letters · doi:10.1016/s0304-3835(01)00847-3 · Cited by 443
Li, Y., Dowbenko, D., & Lasky, L. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109062200 · Cited by 442
Multiple roles of the cell cycle inhibitor p21CDKN1A in the DNA damage response
Cazzalini, O., Scovassi, A. I., Savio, M., Stivala, L. A., & Prosperi, E. (2010) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2010.01.009 · Cited by 433
Hwang, P. M., Bunz, F., Yu, J., Rago, C., Chan, T. A., Murphy, M. P., Kelso, G. F., Smith, R. A. J., Kinzler, K. W., & Vogelstein, B. (2001) · Nature Medicine · doi:10.1038/nm1001-1111 · Cited by 422
Self-citationThe transcriptional targets of p53 in apoptosis control
Yu, J., & Zhang, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.189 · Cited by 420
Drosophila p53 Is a Structural and Functional Homolog of the Tumor Suppressor p53
Ollmann, M., Young, L. M., Di Como, C. J., Karim, F., Belvin, M., Robertson, S., Whittaker, K., Demsky, M., Fisher, W. W., Buchman, A., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)80626-1 · Cited by 412
Cell-cycle arrest versus cell death in cancer therapy
Waldman, T., Zhang, Y., Dillehay, L., Yu, J., Kinzler, K., Vogelstein, B., & Williams, J. (1997) · Nature Medicine · doi:10.1038/nm0997-1034 · Cited by 389
Self-citationChang, B.-D., Xuan, Y., Broude, E. V., Zhu, H., Schott, B., Fang, J., & Roninson, I. B. (1999) · Oncogene · doi:10.1038/sj.onc.1203078 · Cited by 386
Inhibition of p21‐mediated ROS accumulation can rescue p21‐induced senescence
Macip, S., Igarashi, M., Fang, L., Chen, A., Pan, Z., Lee, S. W., & Aaronson, S. A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.9.2180 · Cited by 374
The spindle assembly checkpoint
Rudner, A. D., & Murray, A. W. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80077-9 · Cited by 365
Securin Is Required for Chromosomal Stability in Human Cells
Jallepalli, P. V., Waizenegger, I. C., Bunz, F., Langer, S., Speicher, M. R., Peters, J.-M., Kinzler, K. W., Vogelstein, B., & Lengauer, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00340-3 · Cited by 360
Self-citationTaxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53
Bacus, S. S., Gudkov, A. V., Lowe, M., Lyass, L., Yung, Y., Komarov, A. P., Keyomarsi, K., Yarden, Y., & Seger, R. (2001) · Oncogene · doi:10.1038/sj.onc.1204062 · Cited by 358
Nuclear Accumulation of p21 Cip1 at the Onset of Mitosis: a Role at the G 2 /M-Phase Transition
Dulić, V., Stein, G. H., Far, D. F., & Reed, S. I. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.1.546 · Cited by 353
Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., & Hung, M.-C. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80157-4 · Cited by 353
Various modes of cell death induced by DNA damage
Surova, O., & Zhivotovsky, B. (2013) · Oncogene · doi:10.1038/onc.2012.556 · Cited by 334
Croix, B. S., Flørenes, V. A., Rak, J. W., Flanagan, M., Bhattacharya, N., Slingerland, J. M., & Kerbel, R. S. (1996) · Nature Medicine · doi:10.1038/nm1196-1204 · Cited by 322
(2000) · PubMed · Cited by 314
Activation and activities of the p53 tumour suppressor protein
Bálint, É., & Vousden, K. H. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2128 · Cited by 313
Pyrrolizidine alkaloids in human diet
Prakash, A. S., Pereira, T. N., Reilly, P. E. B., & Seawright, A. A. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5742(99)00010-1 · Cited by 311
Senescence from G2 arrest, revisited
Gire, V., & Dulić, V. (2015) · Cell Cycle · doi:10.1080/15384101.2014.1000134 · Cited by 300
Persistent Telomere Damage Induces Bypass of Mitosis and Tetraploidy
Davoli, T., Denchi, E. L., & de Lange, T. (2010) · Cell · doi:10.1016/j.cell.2010.01.031 · Cited by 298
Shaulian, E., Schreiber, M., Piu, F., Beeche, M., Wagner, E. F., & Karin, M. (2000) · Cell · doi:10.1016/s0092-8674(00)00193-8 · Cited by 295
Sandor, V, Senderowicz, A., Mertins, S., Sackett, D., Sausville, E., Blagosklonny, M. V., & Bates, S. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1327 · Cited by 290
Regulation and Significance of Apoptosis in the Stem Cells of the Gastrointestinal Epithelium
Potten, C. S., Wilson, J. W., & Booth, C. (1997) · STEM CELLS · doi:10.1002/stem.150082 · Cited by 287
Mitra, A. P., Datar, R. H., & Cote, R. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.2073 · Cited by 284
Li, Q., Li, X., Tang, H., Jiang, B., Dou, Y., Gorospe, M., & Wang, W. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25957 · Cited by 280
Tessitore, L., Davit, A., Sarotto, I., & Caderni, G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.619 · Cited by 282
Cell death induced by topoisomerase-targeted drugs: more questions than answers
Kaufmann, S. H. (1998) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(98)00136-5 · Cited by 278
Cell-cycle control and its watchman
Jacks, T., & Weinberg, R. A. (1996) · Nature · doi:10.1038/381643a0 · Cited by 274
Ara-C: Cellular and Molecular Pharmacology
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60703-4 · Cited by 272
PROGNOSTIC MARKERS IN BLADDER CANCER: A CONTEMPORARY REVIEW OF THE LITERATURE
STEIN, J. P., GROSSFELD, G. D., GINSBERG, D. A., ESRIG, D., FREEMAN, J. A., FIGUEROA, A. J., SKINNER, D. G., & COTE, R. J. (1998) · Journal of Urology · doi:10.1016/s0022-5347(01)62747-2 · Cited by 271
p53 and treatment of bladder cancer
Cote, R. J., Esrig, D., Groshen, S., Jones, P. A., & Skinner, D. G. (1997) · Nature · doi:10.1038/385123b0 · Cited by 269
Cytokinesis defects and cancer
Lens, S. M. A., & Medema, R. H. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0084-6 · Cited by 264
Tetraploidy and chromosomal instability are early events during cervical carcinogenesis
Olaharski, A. J., Sotelo, R., Solorza-Luna, G., Gonsebatt, M. E., Guzman, P., Mohar, A., & Eastmond, D. A. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi218 · Cited by 263
Structure of the DNA Repair and Replication Endonuclease and Exonuclease FEN-1
Hosfield, D. J., Mol, C. D., Shen, B., & Tainer, J. A. (1998) · Cell · doi:10.1016/s0092-8674(00)81789-4 · Cited by 261
Role of p21 in Apoptosis and Senescence of Human Colon Cancer Cells Treated with Camptothecin
Han, Z., Wei, W., Dunaway, S., Darnowski, J. W., Calabresi, P., Sedivy, J., Hendrickson, E. A., Balan, K. V., Pantazis, P., & Wyche, J. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112401200 · Cited by 262
Cooperative effects of genes controlling the G2/M checkpoint
Chan, T. A., Hwang, P. M., Hermeking, H., Kinzler, K. W., & Vogelstein, B. (2000) · Genes & Development · doi:10.1101/gad.14.13.1584 · Cited by 262
Self-citationInhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage.
Kurdistani, S. K., Arizti, P., Reimer, C., Sugrue, M. M., Aaronson, S. A., & Lee, S. W. (1998) · PubMed · Cited by 261
Puig, P., Guilly, M., Bouchot, A., Droin, N., Cathelin, D., Bouyer, F., Favier, L., Ghiringhelli, F., Kroemer, G., Solary, E., et al. (2008) · Cell Biology International · doi:10.1016/j.cellbi.2008.04.021 · Cited by 253
Yalcin, S., Zhang, X., Luciano, J. P., Mungamuri, S. K., Marinkovic, D., Vercherat, C., Sarkar, A., Grisotto, M., Taneja, R., & Ghaffari, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800517200 · Cited by 247
pRB plays an essential role in cell cycle arrest induced by DNA damage
Harrington, E. A., Bruce, J. L., Harlow, E., & Dyson, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11945 · Cited by 242
Lafarga, V., Cuadrado, A., Lopez de Silanes, I., Bengoechea, R., Fernandez-Capetillo, O., & Nebreda, A. R. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00210-09 · Cited by 242
Biomarkers for Response to Neoadjuvant Chemoradiation for Rectal Cancer
Kuremsky, J. G., Tepper, J. E., & McLeod, H. L. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.03.003 · Cited by 238
Dutto, I., Tillhon, M., Cazzalini, O., Stivala, L. A., & Prosperi, E. (2015) · Archives of Toxicology · doi:10.1007/s00204-014-1430-4 · Cited by 236
Gualberto, A., Aldape, K., Kozakiewicz, K., & Tlsty, T. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.9.5166 · Cited by 237
p21Waf1/Cip1 as a therapeutic target in breast and other cancers
Weiss, R. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00308-8 · Cited by 237
G1 tetraploidy checkpoint and the suppression of tumorigenesis
Margolis, R. L., Lohez, O. D., & Andreassen, P. R. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10411 · Cited by 232
Clinical implications of p53 mutations
Wallace-Brodeur, R. R., & Lowe, S. W. (1999) · Cellular and Molecular Life Sciences CMLS · doi:10.1007/s000180050270 · Cited by 225
Harper, J. W., & Adams, P. D. (2001) · Chemical Reviews · doi:10.1021/cr0001030 · Cited by 219
BRCA1 Effects on the Cell Cycle and the DNA Damage Response Are Linked to Altered Gene Expression
MacLachlan, T. K., Somasundaram, K., Sgagias, M., Shifman, Y., Muschel, R. J., Cowan, K. H., & El-Deiry, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2777 · Cited by 212
Gervais, J. L. M., Seth, P., & Zhang, H. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.19207 · Cited by 212
APC/CCdc20 Controls the Ubiquitin-Mediated Degradation of p21 in Prometaphase
Amador, V., Ge, S., Santamaría, P. G., Guardavaccaro, D., & Pagano, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.06.013 · Cited by 209
Ando, T., Kawabe, T., Ohara, H., Ducommun, B., Itoh, M., & Okamoto, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106460200 · Cited by 202
p53 Signaling and Cell Cycle Checkpoints
Stewart, Z. A., & Pietenpol, J. A. (2001) · Chemical Research in Toxicology · doi:10.1021/tx000199t · Cited by 202
Selective Activation of p38 MAPK Cascade and Mitotic Arrest Caused by Low Level Oxidative Stress
Kurata, S.-I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000308200 · Cited by 199
Santra, M., Mann, D. M., Mercer, E. W., Skorski, T., Calabretta, B., & Iozzo, R. V. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119507 · Cited by 196
Molecular Pathogenesis and Diagnostics of Bladder Cancer
Mitra, A. P., & Cote, R. J. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092230 · Cited by 194
Hershberger, P. A., Yu, W., Modzelewski, R. A., Rueger, R. M., Johnson, C. S., & Trump, D. L. (2001) · PubMed · Cited by 186
Heerdt, B. G., Houston, M. A., & Augenlicht, L. H. (1997) · PubMed · Cited by 182
Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death.
Barnes, B. J., Kellum, M. J., Pinder, K. E., Frisancho, J. A., & Pitha, P. M. (2003) · PubMed · Cited by 175
Modulation of Growth Factor Action: Implications for the Treatment of Cardiovascular Diseases
Waltenberger, J. (1997) · Circulation · doi:10.1161/01.cir.96.11.4083 · Cited by 177
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activities
Porter, D. C., Farmaki, E., Altilia, S., Schools, G. P., West, D. K., Chen, M., Chang, B.-D., Puzyrev, A. T., Lim, C.-U., Rokow-Kittell, R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206906109 · Cited by 172
p21/p53, Cellular Growth Control and Genomic Integrity
El-Deiry, W. S. (1998) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-71941-7_6 · Cited by 173
Israeli, D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.14.4384 · Cited by 173
p53 Down-Regulates CHK1 through p21 and the Retinoblastoma Protein
Gottifredi, V., Karni-Schmidt, O., Shieh, S.-Y., & Prives, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1066-1076.2001 · Cited by 172
Epidermal Growth Factor Receptor Family and Chemosensitization
Mendelsohn, J., & Fan, Z. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.5.341 · Cited by 171
H2AX Is Required for Cell Cycle Arrest via the p53/p21 Pathway
Fragkos, M., Jurvansuu, J., & Beard, P. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01830-08 · Cited by 170
Wang, Y. A., Elson, A., & Leder, P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.26.14590 · Cited by 170
Inhibition of p53 Transactivation Function by the Human T-Cell Lymphotropic Virus Type 1 Tax Protein
Pise-Masison, C. A., Choi, K.-S., Radonovich, M., Dittmer, J., Kim, S.-J., & Brady, J. N. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1165-1170.1998 · Cited by 170
Metadata
- Authors
- Waldman, T., Lengauer, C., Kinzler, K. W., & Vogelstein, B.
- Affiliations
- Howard Hughes Medical Institute (US)
- Venue
- Nature
- Published
- 1996-06
- Volume
- 381
- Issue
- 6584
- Pages
- 713-716
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2008117987
- Cited by
- 728
- References
- 28
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 2 · 2023: 10 · 2022: 1 · 2021: 6 · 2020: 6 · 2019: 4 · 2018: 12 · 2017: 5 · 2016: 11 · 2015: 5 · 2014: 8 · 2013: 10 · 2012: 18
- FWCI
- 32.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Keywords
- p21, cell cycle checkpoints, cyclin-dependent kinases, DNA damage response, polyploidy, apoptosis, anticancer agents, cell cycle coordination
- MeSH terms
- Antineoplastic Agents, Camptothecin, DNA Damage, Doxorubicin, Enzyme Inhibitors, Etoposide, Fluorescent Dyes, Gamma Rays, Bisbenzimidazole, Humans, Mitosis, Tumor Cells, Cultured, S Phase, Cyclins, Apoptosis, Cyclin-Dependent Kinases, Cyclin-Dependent Kinase Inhibitor p21
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.